Quick answers
- What is Acular?
- Acular is a brand name of Ketorolac tromethamine, a prescription medicine. The FDA NDC Directory lists 1 Acular product in 1 strength and form.
- Who makes Acular?
- Abbvie holds the FDA application for Acular (NDA019700, approved November 9, 1992).
- Is there a generic or store brand of Acular?
- Yes. The FDA NDC Directory lists 14 other products with the same active ingredients, strength and form as a Acular product, 14 of them generic. Ask your pharmacist whether one is right for you.
- Has Acular been recalled?
- No recall linked to Acular products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Acular is
Each Acular product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Ketorolac tromethamine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| ketorolac tromethamine 5 mg/mL solution/ drops (ophthalmic) | Acular | 14 products, 8 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Ketorolac tromethamine →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA019700 | Abbvie | November 9, 1992 | 1 |
Companies that list Acular
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Acular products.
- Allergan, Inc.1 product
Recalls
No recall linked to Acular products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.